An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol

An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol

Abstract Background Gonorrhoea is an ongoing public health concern due to its rising incidence and the emergence of antibiotic resistance. There are an estimated 82 million new Neisseria gonorrhoeae infections each year, with several populations at higher risk for gonococcal infection, including gay...

Full description

Bibliographic Details
Main Authors: Caroline Thng, Evgeny A. Semchenko, Ian Hughes, Maree O’Sullivan, Kate L. Seib
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Public Health
Subjects:
Gonorrhoea
Neisseria gonorrhoeae
Sexually transmitted infection (STI)
Gay and bisexual men (GBM)
Men who have sex with men (MSM)
4CMenB
Online Access:https://doi.org/10.1186/s12889-023-15516-y

Internet

https://doi.org/10.1186/s12889-023-15516-y

Similar Items